Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Barry J. Plant
CFTR Activity Is Enhanced by the Novel Corrector GLPG2222, Given With and Without Ivacaftor in Two Randomized Trials
Journal of Cystic Fibrosis
Child Health
Pulmonary
Pediatrics
Perinatology
Respiratory Medicine
Related publications
Adaptive Pre-Specification in Randomized Trials With and Without Pair-Matching
Statistics in Medicine
Epidemiology
Statistics
Probability
Intensive Blood Pressure Lowering in Patients With and Patients Without Type 2 Diabetes: A Pooled Analysis From Two Randomized Trials
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Low Free Drug Concentration Prevents Inhibition of F508del CFTR Functional Expression by the Potentiator VX-770 (Ivacaftor)
British Journal of Pharmacology
Pharmacology
Group Homogeneity Is Paramount in Randomized Trials
Journal of Thoracic and Cardiovascular Surgery
Respiratory Medicine
Pulmonary
Cardiovascular Medicine
Surgery
Cardiology
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Ivacaftor Therapy in the Context of CFTR Genotype
Clinical Pharmacology and Therapeutics
Pharmacology
Human PrimPol Activity Is Enhanced by RPA
Scientific Reports
Multidisciplinary
Discovery of a Picomolar Potency Pharmacological Corrector of the Mutant CFTR Chloride Channel
Science advances
Multidisciplinary
The Magnitude of Ivacaftor Effects on Fluid Secretion via R117h-CFTR Channels: Human in Vivo Measurements
PLoS ONE
Multidisciplinary
Insulin Secretion Improves in Cystic Fibrosis Following Ivacaftor Correction of CFTR: A Small Pilot Study
Pediatric Diabetes
Internal Medicine
Pediatrics
Endocrinology
Perinatology
Child Health
Metabolism
Diabetes